Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ralimetinib + Tamoxifen in Advanced Breast Cancer
NCT02322853Phase 2Terminated
- Sponsor
- Centre François Baclesse
- Start
- Jan 2015
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ralimetinib in breast cancer, sponsored by Centre François Baclesse. Started Jan 2015; status: terminated.
02
Drugs
ralimetinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02322853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02322853.